Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease

被引：5
|
作者：
Stocco, G. [1 ]
Martelossi, S.
Decorti, G.
Bartoli, F.
Ventura, A.
机构：
[1] Univ Trieste, Dept Biomed Sci, Trieste, Italy
[2] Univ Trieste, IRCCS Burlo Garofolo, Dept Reprod & Dev Sci, Trieste, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2007年 / 26卷 / 07期
关键词：
D O I：
10.1111/j.1365-2036.2007.03417.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1083 / 1084
页数：2
相关论文
共 50 条
  • [21] Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
    Xian-Wen Dong
    World Journal of Gastroenterology, 2010, 16 (25) : 3187 - 3195
  • [22] Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease
    Pashazadeh, Paria
    Marjani, Abdoljalal
    Asadi, Jahanbakhash
    Khoshnia, Masoud
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (04) : 541 - 547
  • [23] Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine
    Zhu Qin
    Cao Qian
    CHINESE MEDICAL JOURNAL, 2012, 125 (20) : 3665 - 3670
  • [24] Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low dose azathioprine
    Campbell, S
    Kingstone, K
    Ghosh, S
    GUT, 2002, 50 : A14 - A14
  • [25] Thiopurine methyltransferase activity and adverse effects of azathioprine in at risk paediatric inflammatory bowel disease patients
    Parry, Christopher
    Hawcutt, Daniel
    Krishnamurthy, Srividyadhari
    Renji, Elizabeth
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1622 - 1622
  • [26] No predictive value of thiopurine S-methyltransferase genotyping for adverse events in inflammatory bowel disease patients established on azathioprine
    Derijks, LJJ
    Curvers, WL
    Hooymans, PM
    van Deventer, SJH
    Hommes, DW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 105 - 105
  • [27] Genetic polymorphisms of the thiopurine S-methyltransferase (TPMT) locus in patients treated with azathioprine for inflammatory bowel disease.
    Rietdijk, ST
    Bartelsman, J
    Hommes, DW
    Vogels, E
    Reitsma, PH
    Van Deventer, SJH
    GASTROENTEROLOGY, 2001, 120 (05) : A622 - A622
  • [28] Thiopurine metabolites and the role of thiopurine methyltransferase activity in inflammatory bowel disease
    Qasim, A
    Buckley, M
    O' Morain, CA
    GUT, 2002, 51 (01) : 141 - 141
  • [29] No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease
    Lindqvist, M.
    Hindorf, U.
    Almer, S.
    Soderkvist, P.
    Strom, M.
    Hjortswang, H.
    Peterson, C.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (9-11): : 1033 - 1037
  • [30] Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease:: impact of thiopurine S-methyltransferase polymorphism
    Schwab, M
    Schäffeler, E
    Marx, C
    Fischer, C
    Lang, T
    Behrens, C
    Gregor, M
    Eichelbaum, M
    Zanger, UM
    Kaskas, BA
    PHARMACOGENETICS, 2002, 12 (06): : 429 - 436
12345